Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Metz

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Sporadic Zollinger-Ellison syndrome with ectopic production of corticotropin: surgical managementN A Ahmad, E E Furth, S S Schwartz, et al.
The American Journal of Gastroenterology|May 16, 2000
Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infectionW D Chey, D C Metz, S Shaw, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 3, 2018
Lack of proton pump inhibitor trial prior to commencing therapy for eosinophilic esophagitis is common in the communityM J Whitson, K L Lynch, Y-X Yang, et al.
Digestive Diseases and Sciences|July 1, 1993
Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndromeJ R Pisegna, J L Doppman, J A Norton, et al.
World Journal of Surgery|July 1, 1993
Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndromeD C Metz, J R Pisegna, V A Fishbeyn, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 hC W Howden, D C Metz, B Hunt, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2004
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitisT O G Kovacs, C Q Lee, Y-L Chiu, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 12, 2008
Evaluation of a locally produced rapid urease test for the diagnosis of Helicobacter pylori infectionD A Levin, G Watermeyer, N Mohamed, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitisD C Metz, C W Howden, M C Perez, et al.
The British Journal of Radiology|October 17, 2002
Radiographically diagnosed antral gastritis: findings in patients with and without Helicobacter pylori infectionS Dheer, M S Levine, R O Redfern, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Sporadic Zollinger-Ellison syndrome with ectopic production of corticotropin: surgical managementN A Ahmad, E E Furth, S S Schwartz, et al.
The American Journal of Gastroenterology|May 16, 2000
Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infectionW D Chey, D C Metz, S Shaw, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 3, 2018
Lack of proton pump inhibitor trial prior to commencing therapy for eosinophilic esophagitis is common in the communityM J Whitson, K L Lynch, Y-X Yang, et al.
Digestive Diseases and Sciences|July 1, 1993
Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndromeJ R Pisegna, J L Doppman, J A Norton, et al.
World Journal of Surgery|July 1, 1993
Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndromeD C Metz, J R Pisegna, V A Fishbeyn, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 hC W Howden, D C Metz, B Hunt, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2004
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitisT O G Kovacs, C Q Lee, Y-L Chiu, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 12, 2008
Evaluation of a locally produced rapid urease test for the diagnosis of Helicobacter pylori infectionD A Levin, G Watermeyer, N Mohamed, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitisD C Metz, C W Howden, M C Perez, et al.
The British Journal of Radiology|October 17, 2002
Radiographically diagnosed antral gastritis: findings in patients with and without Helicobacter pylori infectionS Dheer, M S Levine, R O Redfern, et al.
Pageof 10